Dechra makes success of debut in PP market

debut_Adobe_230x150
By Silas Brown
20 Nov 2019

Dechra Pharmaceuticals, the UK veterinary pharmaceuticals company, has sold euro and dollar US private placement notes, in a debut widely seen as a success.

Santander arranged the transaction, selling €50m of seven year notes and $100m of 10 year PPs according to market sources. This is a new sector for the market, so investors took a while to chew through the credit analysis.

Perhaps the closest company to Dechra to raise PPs ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial